GenSight Biologics S.A. (FRA:G49N)
Germany · Delayed Price · Currency is EUR 0.0588
-0.0021 (-3.45%)
Last updated: Jan 30, 2026, 9:25 AM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €17.4 million as of January 30, 2026. Its market cap has decreased by -48.04% in one year.
Market Cap
17.40M
Enterprise Value
36.14M
Revenue
945.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.06
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 17.40M, a decrease of -93.10%. That is a compound annual growth rate of -24.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 17.40M | -24.43% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |
| ACCENTRO Real Estate AG | 21.00M |
| Petro Matad | 20.45M |
| Pearl Gold AG | 19.25M |
| tick Trading Software AG | 16.61M |
| AdCapital AG | 16.03M |
| Pasinex Resources | 15.72M |
| Consensus Asset Management AB | 15.17M |